The company’s non-lithium, high-temperature batteries can provide up to 24 hours of grid-scale energy storage and reduced-carbon heat for industrial applications, it says.
Ascendis Pharma A/S announced that it has granted Novo Nordisk A/S an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo Nordisk proprietary ...